Home/Filings/4/0001227833-17-000001
4//SEC Filing

PLx Pharma Inc. 4

Accession 0001227833-17-000001

CIK 0001497504operating

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 2:07 PM ET

Size

8.3 KB

Accession

0001227833-17-000001

Insider Transaction Report

Form 4
Period: 2017-06-14
Transactions
  • Purchase

    Common Stock

    2017-06-14$6.88/sh+7,273$50,00278,255 total
  • Purchase

    Warrant

    2017-06-14+7,2737,273 total
    Exercise: $7.50From: 2017-12-15Exp: 2027-06-14Common Stock (7,273 underlying)
Holdings
  • Common Stock

    (indirect: By Mossman Partners LP)
    14,955
  • Common Stock

    (indirect: By Spouse)
    2,009
Footnotes (1)
  • [F1]Issued pursuant to a private placement in connection with the purchase of common stock in a registered direct offering.

Issuer

PLx Pharma Inc.

CIK 0001497504

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001497504

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 2:07 PM ET
Size
8.3 KB